# Filing Detail

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-048135
Filing Date
2024-02-27
Accepted
2024-02-27 17:28:37
Documents
11
Effectiveness Date
2024-02-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-3ASR | d769699ds3asr.htm | S-3ASR | 490936
2 | EX-4.6 | d769699dex46.htm | EX-4.6 | 281430
3 | EX-4.8 | d769699dex48.htm | EX-4.8 | 95451
4 | EX-4.9 | d769699dex49.htm | EX-4.9 | 95243
5 | EX-4.10 | d769699dex410.htm | EX-4.10 | 86566
6 | EX-5.1 | d769699dex51.htm | EX-5.1 | 29168
7 | EX-23.1 | d769699dex231.htm | EX-23.1 | 2418
8 | EX-FILING FEES | d769699dexfilingfees.htm | EX-FILING FEES | 66035
9 | GRAPHIC | g769699g0227044233568.jpg | GRAPHIC | 2534
10 | GRAPHIC | g769699g10a10.jpg | GRAPHIC | 197007
11 | GRAPHIC | g769699g52m47.jpg | GRAPHIC | 598628
| Complete submission text file | 0001193125-24-048135.txt |  | 2234526

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277424 | Film No.: 24688741
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)